TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Seroconversion of HBeAg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Negativization of HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean values of MDPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean values of MDAPE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean values of wobble
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intent to change clinical practice
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in mean arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of first-dose hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in n-6 fatty acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tonographic facility of outflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood-aqueous barrier permeability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Worst pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nonresponders percentage
Endpoint domain: Adverse events/effects
Primary endpoint: Systemic exposure to atenolol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Freedom from primary diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Infusion rates of mivacurium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time (train-of-four ratio 70%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of mivacurium and its trans-trans isomer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Mortality in ICU
Endpoint domain: Mortality/survival
Primary endpoint: Cure of DIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall postoperative complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of postoperative pancreatic fistula (POPF)
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of postoperative pancreatic fistula (POPF)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient-reported trismus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal interincisal distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving HbA1c < 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heavy drinking rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marijuana use rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tobacco abstinence for the past 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tobacco abstinence for the past 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum total NO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GSH‐Px activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative portal vein thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Recurrence rate for obstructed defecation syndrome and stress urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form 36 Health Survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall Satisfaction Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of msHDSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of responders with at least a 2-point drop
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of responders with at least a 75% reduction in sweat weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of documented hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of severe hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of shoulder pain
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness in preventing smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention to provide a future donation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: positive donation attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: confidence in ability to avoid adverse reactions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: attempted donation rates at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrence of nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of hospitalization for cardiovascular conditions
Endpoint domain: Mortality/survival
Primary endpoint: Rates of cardiovascular deaths
Endpoint domain: Mortality/survival
Primary endpoint: Reported side effects
Endpoint domain: Adverse events/effects
Primary endpoint: cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: effective rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: healing period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean area under the curve (AUC(0,24 h))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of reduced ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Protein assimilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: self-efficacy score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 2-h postprandial plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: newborn hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Decreased patient-perceived QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Residue estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in primary caregivers burden of care
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Mitral Regurgitation (MR) jet area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: E velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cure rates of H. pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of procedure-related troubles
Endpoint domain: Adverse events/effects
Primary endpoint: Length of the analgesic procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sweat rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hopkins Verbal Learning Test Recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrimination Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spelling test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of fatal and non-fatal stroke
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of sodium load excreted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: daytime systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-h systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: perception of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of muffins
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: retreatment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular single vision (BSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diplopia free in downgaze
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excyclotorsion reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid positive volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of respiratory dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time of mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage time intraduodenal pH <4.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical reactions to lupine-enriched pasta
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic change in total modified Sharp score (TSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of ventricular fibrillation
Endpoint domain: Mortality/survival
Primary endpoint: time to 30% improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SBR (stillbirth rate)
Endpoint domain: Mortality/survival
Primary endpoint: ENND rate (early neonatal death rate)
Endpoint domain: Mortality/survival
Primary endpoint: direct obstetric CFR (case fatality rate)
Endpoint domain: Mortality/survival
Primary endpoint: Muscle pain on SIMVA
Endpoint domain: Adverse events/effects
Primary endpoint: rate of unplanned interventions and visits
Endpoint domain: Adverse events/effects
Primary endpoint: Use of supplemental analgesic medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 1-year survival
Endpoint domain: Mortality/survival
Primary endpoint: 28-day all-cause mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: disappearance of S.R.H.
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma citrulline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum iFABP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extra nasal symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak nasal inspiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of mild/moderate ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Risk of severe ED
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement on untrained goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Maintenance of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Better preparation for doctors' visits
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Local progression-free survival (LPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Distant metastasis-free survival (DMFS)
Endpoint domain: Mortality/survival
Primary endpoint: One-year cumulative survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable soft tissues and increased papilla scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of detecting pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: actigraphic total sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: apnea-hypopnea index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Osteoporosis development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Vagal activity measured by HF power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: survival free of disabling stroke or reoperation
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative proportion of patients undergoing reoperation for glaucoma
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative complications associated with reoperation or vision loss
Endpoint domain: Adverse events/effects
Primary endpoint: VAS of shoulder pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropeptide Y (NPY)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low frequency/high frequency ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive rate of cancer cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Procedure-related discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Local anesthetic volume used
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: feeding scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: infant teaching scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Difficulty of laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of deep scotoma as an indicator of full thickness macular hole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of deep scotoma as an indicator of full thickness macular hole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of relative scotoma as an indicator of full thickness macular hole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of relative scotoma as an indicator of full thickness macular hole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postvoid residual
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Distal embolization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: bench press strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: squat strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leg power improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with GP-led melanoma follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: fewer opiate positive urine tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of self-reported heroin use
Endpoint domain: Life impact
Endpoint subdomain: Substance use
Primary endpoint: days of self-reported alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Substance use
Primary endpoint: serum uric acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in functional class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUB (Adverse Upper Airway Blockage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RI (Respiratory Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean instability time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical decisions reached faster
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Scheduled follow-up sooner
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Self-Reported Exercise (SRE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Engagement (OEs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Directed Physical Activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in digoxin area under the curve (AUC(0-24))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in digoxin maximal plasma concentration (C(max))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in digoxin plasma concentration at 24 hours (C(trough))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of movements to complete cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Path length to complete cholecystectomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical Ground-Reaction Forces (VGRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth shade lightness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response (CR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for rescue anti-emetics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 24-hour weighted mean FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of anterior knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes-related distress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intensity of spontaneous panic attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of conventional therapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MI as an independent predictor of survival
Endpoint domain: Mortality/survival
Primary endpoint: Preeclampsia risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Hypertensive disorders risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Plasma glucose level after oral glucose challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Systemic humoral and cellular responses to cow's milk proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean total cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of post-AC cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mutans streptococci and lactobacilli levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New caries lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Driving impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability (Cohen kappa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes